These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32816367)

  • 61. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy TM; Chalder T; McCrone P; Darnley S; Knapp M; Jones RH; Wessely S
    Health Technol Assess; 2006 Jun; 10(19):iii-iv, ix-x, 1-67. PubMed ID: 16729918
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A feasibility study investigating the impact of a dietitian-led low in fermentable oligosaccharide, disaccharide, monosaccharide and polyols diet group education programme with irritable bowel syndrome.
    Chan D; Skidmore P; O'Brien L; Watson S; Gearry R
    N Z Med J; 2020 Sep; 133(1522):42-51. PubMed ID: 32994615
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical application of dietary therapies in irritable bowel syndrome.
    Rej A; Avery A; Ford AC; Holdoway A; Kurien M; McKenzie Y; Thompson J; Trott N; Whelan K; Williams M; Sanders DS
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):307-316. PubMed ID: 30240475
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Economic burden of irritable bowel syndrome in China.
    Zhang F; Xiang W; Li CY; Li SC
    World J Gastroenterol; 2016 Dec; 22(47):10450-10460. PubMed ID: 28058026
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
    Zahedi MJ; Behrouz V; Azimi M
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In-patient discharge rates for the irritable bowel syndrome - an analysis of national trends in the United States from 1997 to 2010.
    Sethi S; Wadhwa V; LeClair J; Mikami S; Park R; Jones M; Sethi N; Brown A; Lembo A
    Aliment Pharmacol Ther; 2013 Dec; 38(11-12):1338-46. PubMed ID: 24206371
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association of irritable bowel syndrome and venous thromboembolism.
    Zöller B; Ohlsson H; Waehrens R; Sundquist J; Sundquist K
    Scand J Gastroenterol; 2018; 53(7):784-789. PubMed ID: 29688100
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.
    Staudacher HM; Whelan K; Irving PM; Lomer MC
    J Hum Nutr Diet; 2011 Oct; 24(5):487-95. PubMed ID: 21615553
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influence of Webinar-Based Learning on Practice of Percutaneous Nephrolithotomy: Outcomes of a Global Survey.
    Lim EJ; Tanidir Y; Ganesan S; Maheshwari PN; Tanwar H; Ragoori D; Ganpule AP; Kumar S; Mishra DK; Mohan VC; Balakrishnan AK; Wroclawski ML; Gadzhiev N; Castellani D; Teoh JY; Chew BH; Smith D; Somani BK; Gauhar V
    J Endourol; 2022 Feb; 36(2):279-286. PubMed ID: 34583533
    [No Abstract]   [Full Text] [Related]  

  • 70. Patient educational media preferences for information about irritable bowel syndrome (IBS).
    Halpert A; Dalton CB; Palsson O; Morris C; Hu Y; Bangdiwala S; Hankins J; Norton N; Drossman DA
    Dig Dis Sci; 2008 Dec; 53(12):3184-90. PubMed ID: 18463981
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The burden and management of patients with IBS: Results from a survey in spanish gastroenterologists.
    Almansa C; Díaz-Rubio M; Rey E
    Rev Esp Enferm Dig; 2011 Nov; 103(11):570-5. PubMed ID: 22149558
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Societal costs for irritable bowel syndrome--a population based study.
    Hillilä MT; Färkkilä NJ; Färkkilä MA
    Scand J Gastroenterol; 2010 May; 45(5):582-91. PubMed ID: 20166844
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet.
    Moore JS; Gibson PR; Perry RE; Burgell RE
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):201-205. PubMed ID: 28303579
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Doctor-patient interaction for irritable bowel syndrome in primary care: a systematic perspective.
    Dhaliwal SK; Hunt RH
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1161-6. PubMed ID: 15489576
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Utility of a webinar to educate trainees on UK core surgical training (CST) selection - A cross sectional study and future implications amidst the COVID-19 pandemic.
    Patel NM; Khajuria A; Khajuria A
    Ann Med Surg (Lond); 2020 Nov; 59():35-40. PubMed ID: 32922774
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IMPACT webinars: Improving Patient Access to genetic Counselling and Testing using webinars-the Alberta experience with hypertrophic cardiomyopathy.
    Christian S; Tagoe J; Delday L; Bernier FP; Kohut R; Ferrier R
    J Community Genet; 2022 Feb; 13(1):81-89. PubMed ID: 34766249
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acceptability, appropriateness and feasibility of webinar in strengthening research capacity in COVID-19 era in Nigeria.
    Komolafe AO; Ijarotimi OA; Adetutu OM; Okunola OA; Ojo TO; Oyinlola FF; Olorunmoteni OE; Olodu MD; Agunbiade OM; Otuyemi OD
    Niger Postgrad Med J; 2022; 29(4):288-295. PubMed ID: 36308257
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Telehealth for Pediatric Gastroenterology Care Now: The Transition to Telehealth and the Impact of Webinar-Based Didactics.
    Setty M; Mougey EB; Berg E; Rosen JM; Lee J; Li BUK; Venkatesh R; Franciosi JP
    JPGN Rep; 2022 May; 3(2):e182. PubMed ID: 37168904
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease.
    Testa A; Imperatore N; Rispo A; Rea M; Tortora R; Nardone OM; Lucci L; Accarino G; Caporaso N; Castiglione F
    Dig Dis; 2018; 36(4):271-280. PubMed ID: 29763907
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet.
    Jones MP; Bratten J; Keefer L
    Am J Gastroenterol; 2007 Oct; 102(10):2232-7. PubMed ID: 17680842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.